Dr. Rupali Ramchandra Miskar, MD

Dr. Miskar practices at Montgomery General Hospital in Montgomery, West Virginia, part of Montgomery General Hospital.

Dr. Miskar's NPI, 1023394244, was assigned on November 2, 2011. Dr. Miskar holds West Virginia license 25974.

Dr. Miskar's primary practice is Montgomery General Hospital, at 401 Sixth Avenue, Montgomery, WV 25136 in Fayette County. The practice phone is (304) 442-5151.

Dr. Miskar's primary practice is Montgomery General Hospital in Montgomery, West Virginia, part of Montgomery General Hospital. Dr. Miskar is also affiliated with Select Specialty Hospital - Charleston. The medical group on file is Montgomery General Hospital. Dmand AI also links Dr. Miskar to 1 more hospital and 6 medical groups, each named with a free account. Dr. Miskar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miskar practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Miskar's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Miskar is board certified in internal medicine by the American Board of Internal Medicine. Dr. Miskar is licensed in West Virginia.

CMS data shows 1,217 Medicare services from Dr. Miskar across 6 procedure codes in 2024, for 284 Medicare patients. Medicare paid $104,035 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 284 Medicare patients who saw Dr. Miskar in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miskar's median patient age at 73, with 58% women.

In 2024, Dr. Miskar wrote 73 Medicare Part D claims for 39 patients. 75% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $624 in total drug cost. In 2021, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Miskar for performance year 2024, reported through an alternative payment model (APM). Dr. Miskar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 22 general payments to Dr. Miskar from 14 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $142.